Iterum Therapeutics's total assets for Q3 2025 were $32.50M, a decrease of -4.44% from the previous quarter. ITRM total liabilities were $39.88M for the fiscal quarter, a 5.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.